SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019884
Filing Date
2021-08-16
Accepted
2021-08-16 06:31:03
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1006648
2 ex31-1.htm EX-31.1 7767
3 ex32-1.htm EX-32.1 4568
  Complete submission text file 0001493152-21-019884.txt   4515609

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sign-20210630.xsd EX-101.SCH 31968
5 XBRL CALCULATION FILE sign-20210630_cal.xml EX-101.CAL 51053
6 XBRL DEFINITION FILE sign-20210630_def.xml EX-101.DEF 110362
7 XBRL LABEL FILE sign-20210630_lab.xml EX-101.LAB 263899
8 XBRL PRESENTATION FILE sign-20210630_pre.xml EX-101.PRE 215384
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 632711
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 211174361
SIC: 3841 Surgical & Medical Instruments & Apparatus